ILMN

Illumina
D

ILMN

80.380
USD
-0.16
(-0.20%)
مغلق
حجم التداول
65,069
الربح لكل سهم
4
العائد الربحي
-
P/E
-13
حجم السوق
12,724,154,000
الأفكار والتحليلات
هشام منسي
هشام منسي
منذ 10 أشهر
buy
2024-07-24 05:43
ILMN Chart
المزيد
أصول ذات صلة
ABT
ABT
-0.240
(-0.18%)
131.240 USD
AMGN
AMGN
-0.04
(-0.01%)
271.89 USD
BDX
BDX
-0.820
(-0.48%)
171.380 USD
DGX
DGX
1.620
(0.96%)
171.200 USD
DHR
DHR
-2.900
(-1.55%)
184.570 USD
GILD
GILD
0.670
(0.63%)
107.390 USD
LH
LH
0.680
(0.28%)
242.510 USD
TMO
TMO
-6.77
(-1.69%)
393.52 USD
المزيد
الأخبار المقالات

العنوان: Illumina

القطاع: Healthcare
الصناعة: Diagnostics & Research
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.